We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

130 hedge funds and large institutions have $357M invested in Precision BioSciences in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 42 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more call options, than puts

Call options by funds: $2.6M | Put options by funds: $1.53M

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

14% more capital invested

Capital invested by funds: $313M → $357M (+$44.3M)

2% more funds holding

Funds holding: 128 → 130 (+2)

5% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 42

0.11% less ownership

Funds ownership: 1.77% → 1.67% (-0.11%)

Holders
130
Holders Change
+2
Holders Change %
+1.56%
% of All Funds
2.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
44
Reduced
42
Closed
18
Calls
$2.6M
Puts
$1.53M
Net Calls
+$1.07M
Net Calls Change
+$1.14M

Top Buyers

Rank Fund Capital Flow
1
CS
Candriam SCA
Luxembourg
+$6.34M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$4.8M
3
JP Morgan Chase
JP Morgan Chase
New York
+$3.13M
4
Morgan Stanley
Morgan Stanley
New York
+$2.18M
5
Capital World Investors
Capital World Investors
California
+$2.07M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$23.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.38M
3
UBS Group
UBS Group
Switzerland
-$3.13M
4
BlackRock
BlackRock
New York
-$2.97M
5
GTC
Ghost Tree Capital
New York
-$2.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
Daiwa Securities Group
126
Daiwa Securities Group
Japan
$1K – – –
First Manhattan
127
First Manhattan
New York
$1K – – –
IRC
128
Investors Research Corp
Georgia
$1K – – –
SIC
129
Salem Investment Counselors
North Carolina
$1K +$901 +3 New
AIG
130
American International Group
New York
$333 -$4.5K -15 -2%
GTC
131
Ghost Tree Capital
New York
– -$2.07M -6,667 Closed
Balyasny Asset Management
132
Balyasny Asset Management
Illinois
– -$1.71M -5,499 Closed
PVI
133
Pura Vida Investments
New York
– -$1.05M -3,370 Closed
California Public Employees Retirement System
134
California Public Employees Retirement System
California
– -$978K -3,150 Closed
MIFH
135
Migdal Insurance & Financial Holdings
Israel
– -$686K -2,210 Closed
TNB
136
Thomasville National Bank
Georgia
– -$331K -1,829 Closed
MLICM
137
Metropolitan Life Insurance Company (MetLife)
New York
– -$129K -415 Closed
1C
138
1623 Capital
Virginia
– -$127K -409 Closed
TCM
139
Traynor Capital Management
Pennsylvania
– -$113K -367 Closed
SG Americas Securities
140
SG Americas Securities
New York
– -$103K -331 Closed
SWM
141
Spire Wealth Management
Virginia
– -$74K -249 Closed
Pacer Advisors
142
Pacer Advisors
Pennsylvania
– -$69K -221 Closed
Bank of Montreal
143
Bank of Montreal
Ontario, Canada
– -$19K -69 Closed
SPIA
144
Steward Partners Investment Advisory
New York
– -$7.25K -23 Closed
PHK
145
Point72 Hong Kong
Hong Kong
– -$6K -20 Closed
MF
146
Manchester Financial
California
– -$6K -18 Closed
SBL
147
Sargent Bickham Lagudis
Colorado
– -$2K -7 Closed
TIM
148
Tortoise Investment Management
New York
– -$1K -4 Closed
2 3 4 5
6

DTIL Hedge Fund Activity: Q2 2021 in Review

130 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2021, worth a combined $357M — up 14% from $313M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new DTIL positions and 18 closed out — a net gain of 3 holders — while 44 added to existing stakes and 42 trimmed.

The largest buyer was Candriam SCA, opening a new position worth an estimated $6.34M. The largest seller was State Street, cutting an estimated $23.7M.

  • 130 institutional investors held Precision BioSciences (DTIL) as of Q2 2021, up from 128 in Q1 2021.
  • Funds reported $357M of Precision BioSciences stock for Q2 2021, up 14% quarter-over-quarter.
  • 21 funds opened new Precision BioSciences positions in Q2 2021 and 18 closed out, a net change of +3 holders.
  • The largest Precision BioSciences buyer in Q2 2021 was Candriam SCA, an estimated $6.34M added.
  • The largest Precision BioSciences seller in Q2 2021 was State Street, an estimated $23.7M sold.

Based on aggregated 13F filings for Q2 2021.